Literature DB >> 29339953

Overview of the Updated AASLD Guidelines for the Management of HCC.

Julie K Heimbach1.   

Abstract

Year:  2017        PMID： 29339953      PMCID： PMC5763563     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

Authors:  Jordi Bruix; Jean-Luc Raoul; Morris Sherman; Vincenzo Mazzaferro; Luigi Bolondi; Antonio Craxi; Peter R Galle; Armando Santoro; Michel Beaugrand; Angelo Sangiovanni; Camillo Porta; Guido Gerken; Jorge A Marrero; Andrea Nadel; Michael Shan; Marius Moscovici; Dimitris Voliotis; Josep M Llovet
Journal:  J Hepatol       Date:  2012-06-19       Impact factor: 25.083

2.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Authors:  Pierre-Alain Clavien; Mickael Lesurtel; Patrick M M Bossuyt; Gregory J Gores; Bernard Langer; Arnaud Perrier
Journal:  Lancet Oncol       Date:  2011-10-31       Impact factor: 41.316

Review 3.  Downstaging hepatocellular carcinoma: A systematic review and pooled analysis.

Authors:  Neehar D Parikh; Akbar K Waljee; Amit G Singal
Journal:  Liver Transpl       Date:  2015-09       Impact factor: 5.799

4.  Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

Authors:  Bruno Vincenzi; Massimo Di Maio; Marianna Silletta; Loretta D'Onofrio; Chiara Spoto; Maria Carmela Piccirillo; Gennaro Daniele; Francesca Comito; Eliana Maci; Giuseppe Bronte; Antonio Russo; Daniele Santini; Francesco Perrone; Giuseppe Tonini
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

5.  Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.

Authors:  Amit G Singal; Anjana Pillai; Jasmin Tiro
Journal:  PLoS Med       Date:  2014-04-01       Impact factor: 11.069
  5 in total
  8 in total

1.  Core implementation strategies for improving cirrhosis care in the Veterans Health Administration.

Authors:  Vera Yakovchenko; Timothy R Morgan; Edward J Miech; Brittney Neely; Carolyn Lamorte; Sandra Gibson; Lauren A Beste; Heather McCurdy; Dawn Scott; Rachel I Gonzalez; Angela M Park; Byron J Powell; Jasmohan S Bajaj; Jason A Dominitz; Maggie Chartier; David B Ross; Matthew J Chinman; Shari S Rogal
Journal:  Hepatology       Date:  2022-03-17       Impact factor: 17.298

Review 2.  Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma.

Authors:  Yetirajam Rajesh; Devanand Sarkar
Journal:  Cancers (Basel)       Date:  2020-05-20       Impact factor: 6.639

Review 3.  18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches.

Authors:  Arno Kornberg; Helmut Friess
Journal:  Therap Adv Gastroenterol       Date:  2019-03-19       Impact factor: 4.802

4.  Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.

Authors:  Yue Han; Wei-Hua Zhi; Fei Xu; Chen-Bo Zhang; Xiao-Qian Huang; Jian-Feng Luo
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

Review 5.  Novel biomarkers for the management of chronic hepatitis B.

Authors:  Takako Inoue; Yasuhito Tanaka
Journal:  Clin Mol Hepatol       Date:  2020-06-15

Review 6.  Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer.

Authors:  Joanne Marie O'Rourke; Vandana Mridhu Sagar; Tahir Shah; Shishir Shetty
Journal:  World J Gastroenterol       Date:  2018-10-21       Impact factor: 5.742

7.  A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies.

Authors:  Yan Zhao; Yonghong Zhang; Qi Wang; Liang Ma; Jianjun Li; Chunwang Yuan; Jianping Sun; Kang Li; Ling Qin; Chaoran Zang; Yanan Zhao
Journal:  Cancer Manag Res       Date:  2019-12-20       Impact factor: 3.989

8.  Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome.

Authors:  Omar A Saldarriaga; Bradley Dye; Judy Pham; Timothy G Wanninger; Daniel Millian; Michael Kueht; Benjamin Freiberg; Netanya Utay; Heather L Stevenson
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.